PUBLISHER: Orion Market Research | PRODUCT CODE: 1064838
PUBLISHER: Orion Market Research | PRODUCT CODE: 1064838
Global Nuclear Medicine Isotopes Market Size, Share & Trends Analysis Report by Type (Stable Isotopes and Radio Isotopes), By Application (Nuclear Therapy, Equipment Radioactive Source, and Diagnosis) and Forecast (2020-2026)
The global nuclear medicine isotope market is anticipated to grow at a considerable CAGR during the forecast period. The growing usage of nuclear medicine isotopes in treatment of several disorders is a key factor driving the growth of the global nuclear medicine isotopes market. Nuclear medicine is used to diagnose and test the effect of a wide range of diseases, including heart diseases, tumors, gastrointestinal, neurological disorders, and endocrine disorders, as well as other abnormalities in the body.
The global nuclear medicine isotope market is segmented based on type and application. Based on type, the market is segmented into stable isotopes and radio isotopes. Based on application, the nuclear medicine isotope market is segmented into nuclear therapy, equipment radioactive source, and diagnosis.
Geographically, the global nuclear medicine isotope market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global nuclear medicine isotope market include Bayer AG, General Electric Co., Siemens Healthcare, Cardinal Health, Inc., and Nordion Inc.
Market Segmentation
The Report Covers